QuidelOrtho Corporation (QDEL)

Market Cap	2.65B
Revenue (ttm)	3.00B
Net Income (ttm)	-10.10M
Shares Out	66.85M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	15.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	902,282
Open	40.75
Previous Close	40.82
Day's Range	38.91 - 40.75
52-Week Range	37.78 - 95.02
Beta	0.12
Analysts	Hold
Price Target	61.60 (+55.2%)
Earnings Date	May 8, 2024

About QDEL

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 7,100
• Stock Exchange: NASDAQ
• Ticker Symbol: QDEL

Analyst Forecast

According to 7 analysts, the average rating for QDEL stock is "Hold." The 12-month stock price forecast is $61.6, which is an increase of 55.20% from the latest price.

Price Target

$61.6

(55.20% upside)

Analyst Consensus: Hold